MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 102 filers reported holding MAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77,875 | -30.9% | 24,960 | +1.6% | 0.00% | 0.0% |
Q2 2023 | $112,767 | +10.1% | 24,568 | +18.7% | 0.00% | 0.0% |
Q1 2023 | $102,455 | -6.6% | 20,698 | +3.0% | 0.00% | 0.0% |
Q4 2022 | $109,708 | -12.9% | 20,093 | +4.0% | 0.00% | 0.0% |
Q3 2022 | $126,000 | +38.5% | 19,315 | +0.3% | 0.00% | 0.0% |
Q2 2022 | $91,000 | -26.6% | 19,256 | +8.7% | 0.00% | 0.0% |
Q1 2022 | $124,000 | -30.7% | 17,718 | +0.9% | 0.00% | 0.0% |
Q4 2021 | $179,000 | – | 17,566 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |